MUTATIONAL APPROACHES TO INVESTIGATION OF PROTEIN STRUCTURE, FUNCTION & FOLDING
研究蛋白质结构、功能的突变方法
基本信息
- 批准号:6478962
- 负责人:
- 金额:$ 5.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Human CDI proteins are a family of norimajor histocompatibility
complex (MHC) encoded transmembrane glycoproteins expressed in
association with 02-microglobulin on the surface of antigen-presenting
cells (APCs). Unlike the well known M[HC class I and class 11
proteins that present peptide antigens to T cells, the human group I
CD1 proteins (CD1a, CD1b andCDlc) mediate specific T cell recognition
of bacterial lipid and glycolipid antigens. Previous studies of
mycobacteria specific T cells have identified two classes of
CDI-restricted lipid antigens. These are the free mycolic acids, a
family of cc-branched, 0-hydroxy long chain fatty acids, and the
phosphatidylinositol-containing glycolipids including
lipoarabinomannan (LAM) andthe phosphatidylinositol mannosides (PlMs).
Mycohacterium leprae infection has recently revealed evidence for a
third class of CDI restricted lipid antigens. The CDI proteins play a
central role in the specific T cell recognition of foreign lipid
antigens, but the molecular mechanisms underlying lipid antigen
presentation are not known. During this past year, we have identified
a novel CDI-restricted glycolipid antigen, glucose monomycolate
(GM[M), which is allowing a systematic analysis of the structural
features that determine its recognition by T cells. Analogues of GNM
that differed substantially in their acyl chain lengths and other
chemical features of the lipid moiety were recognized by T cells. In
contrast, T cells demonstrated fine specificity for the carbohydrate
portion ?of mycolyl glycolipids, even discriminating among
carbohydrate isomers differing only in the orientation of a single
hydroxyl group (e.g., only glucose and not mannose or galactose). In
combination with recent studies of the crystal structure of CD1, these
results provide strong support for a molecular model of antigen
presentation in which the acyl chains of the antigen bind relatively
nonspecifically within the deep, hydrophobic pocket of the CD1
protein, resulting in presentation of the hydrophilic elements of
antigens for highly specific interactions with the T cell receptor.
人类 CDI 蛋白是一个主要组织相容性正常的家族
复合体(MHC)编码的跨膜糖蛋白表达于
与抗原呈递表面的 02-微球蛋白结合
细胞(APC)。 与众所周知的M[HC I类和11类
将肽抗原呈递给 T 细胞(人类 I 组)的蛋白质
CD1 蛋白(CD1a、CD1b 和 CDlc)介导特异性 T 细胞识别
细菌脂质和糖脂抗原。 以前的研究
分枝杆菌特异性 T 细胞已鉴定出两类
CDI 限制性脂质抗原。 这些是游离的分枝菌酸,
cc-支链、0-羟基长链脂肪酸家族,以及
含磷脂酰肌醇的糖脂包括
脂阿拉伯甘露聚糖 (LAM) 和磷脂酰肌醇甘露糖苷 (PLMs)。
最近发现了麻风分枝杆菌感染的证据
第三类CDI限制性脂质抗原。 CDI 蛋白发挥着
T 细胞对外来脂质的特异性识别中发挥核心作用
抗原,但脂质抗原的分子机制
介绍尚不清楚。 在过去的一年里,我们确定了
一种新型 CDI 限制性糖脂抗原,葡萄糖单菌酸酯
(GM[M),它允许对结构进行系统分析
决定其被 T 细胞识别的特征。 GNM 类似物
它们的酰基链长度和其他方面有很大不同
T 细胞识别脂质部分的化学特征。 在
相比之下,T 细胞对碳水化合物表现出良好的特异性
部分 ? 菌基糖脂,甚至区分
碳水化合物异构体仅在单个方向上有所不同
羟基(例如,只有葡萄糖,没有甘露糖或半乳糖)。 在
结合最近对CD1晶体结构的研究,这些
结果为抗原分子模型提供了强有力的支持
抗原的酰基链相对结合的呈现
非特异性地位于 CD1 的深层疏水口袋内
蛋白质,导致亲水元素的呈现
与 T 细胞受体高度特异性相互作用的抗原。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher James MCKNIGHT其他文献
Christopher James MCKNIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher James MCKNIGHT', 18)}}的其他基金
A Console Upgrade and Cryogenic Probe for a 500 MHz NMR System for Biomedical Res
用于生物医学研究的 500 MHz NMR 系统的控制台升级和低温探头
- 批准号:
8448512 - 财政年份:2013
- 资助金额:
$ 5.36万 - 项目类别:
Localizing and Modeling Headpiece Domains on F-Actin
F-肌动蛋白上头件结构域的本地化和建模
- 批准号:
6710140 - 财政年份:2002
- 资助金额:
$ 5.36万 - 项目类别:
Localizing and Modeling Headpiece Domains on F-Actin
F-肌动蛋白上头件结构域的本地化和建模
- 批准号:
6863713 - 财政年份:2002
- 资助金额:
$ 5.36万 - 项目类别:
Localizing and Modeling Headpiece Domains on F-Actin
F-肌动蛋白上头件结构域的本地化和建模
- 批准号:
6622010 - 财政年份:2002
- 资助金额:
$ 5.36万 - 项目类别:
Localizing and Modeling Headpiece Domains on F-Actin
F-肌动蛋白上头件结构域的本地化和建模
- 批准号:
7026393 - 财政年份:2002
- 资助金额:
$ 5.36万 - 项目类别:
Localizing and Modeling Headpiece Domains on F-Actin
F-肌动蛋白上头件结构域的本地化和建模
- 批准号:
6438240 - 财政年份:2002
- 资助金额:
$ 5.36万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 5.36万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 5.36万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 5.36万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 5.36万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 5.36万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 5.36万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 5.36万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




